Home
Conditions
Carcinoma, Non-Small-Cell Lung

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,031 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

NCT06518018

Conditions: Advanced Stage NSCLC, Barakat syndrome, Bronchial Neoplasms, +11 more
Locations: The Second People's Hospital of Neijiang Neijiang, Sichuan, China

View Trial Details

Active, Not Recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations: CARTI Cancer Center Little Rock, Arkansas, United States

City of Hope Duarte, California, United States

Providence Saint John's Cancer Institute Santa Monica, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

View all 16 locations

View Trial Details

Active, Not Recruiting

Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.

NCT01456429

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Universitair Ziekenhuis Gent Ghent, Belgium

Universitaire Ziekenhuizen leuven Leuven, Belgium

Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

View Trial Details

Active, Not Recruiting

Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC

NCT05244213

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC

NCT04143607

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Beijing Chest Hospital,Capital Medical University Beijing, Beijing Municipality, China

Jiangsu Cancer Hospital Nanjing, Jiangsu, China

View Trial Details

Active, Not Recruiting

Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer

NCT03299478

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Rigshospitalet Copenhagen, København Ø, Denmark

Odense Universitetshospital Odense, Denmark

Oslo University Hospital Oslo, Norway

University Hospital of North Norway Tromsø, Norway

View Trial Details

Active, Not Recruiting

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

NCT03870464

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +21 more
Locations: Department of Oncology, Odense University Hospital Odense, Denmark

View Trial Details

Active, Not Recruiting

JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations

NCT06391944

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Li Zhang Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy

NCT05383716

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Active, Not Recruiting

Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer

NCT02991924

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: National Cancer Center (NCC) Korea Goyang-si, Gyeonggi-do, South Korea

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions